Triad Isotopes Announces Investment By Parthenon Capital
Published: Jan 16, 2007
ORLANDO, Fla.--(BUSINESS WIRE)--Triad Isotopes Inc. announced today the acquisition and merger of three leading nuclear pharmacy operators, Diversified Pharmacy Group, Cox Nuclear Pharmacies and Coastal Nuclear Pharmacies. Triad was funded by Parthenon Capital, a leading middle market private equity fund with offices in San Francisco and Boston. As a combined business, Triad now constitutes one of the largest independent nuclear pharmacy companies in the United States. Triad was formed in partnership with Dom Meffe who will become CEO of the company. The founders of each of the merged companies, Steve Putnal, William Cox, and Ed Fennel, will continue as senior members of Triad’s management team.